Weidong Jiang Selected Research

Weidong Jiang Research Topics

Disease

14	Neoplasms (Cancer) 11/2021 - 10/2004
5	Inflammation (Inflammations) 08/2022 - 10/2004
4	Carcinogenesis 11/2019 - 10/2004
3	Neoplasm Metastasis (Metastasis) 11/2019 - 08/2004
2	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 11/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 11/2019
2	Hypoxia (Hypoxemia) 09/2020 - 09/2013
2	Ovarian Neoplasms (Ovarian Cancer) 01/2013 - 05/2010
1	Bone Fractures (Bone Fracture) 05/2022
1	Bone Diseases (Bone Disease) 01/2022
1	Heart Failure 01/2022
1	Squamous Cell Carcinoma of Head and Neck 12/2021
1	Mouth Neoplasms (Oral Cancer) 12/2021
1	Exanthema (Rash) 11/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2021
1	Infections 10/2021
1	COVID-19 10/2021
1	Adenocarcinoma 03/2021
1	Liver Neoplasms (Liver Cancer) 12/2018
1	Fibrosis (Cirrhosis) 10/2018
1	Body Weight (Weight, Body) 10/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Kidney Neoplasms (Kidney Cancer) 01/2018
1	Atherosclerosis 03/2016
1	Hypertension (High Blood Pressure) 09/2013
1	Stomach Neoplasms (Stomach Cancer) 04/2013
1	Plague (Bubonic Plague) 01/2011
1	Atherosclerotic Plaque (Atheroma) 01/2011
1	Aneuploidy (Aneuploid) 09/2010
1	Breast Neoplasms (Breast Cancer) 08/2004
1	Leukemia 03/2003
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2003

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2021 - 10/2004
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 05/2010
2	Circular RNAIBA 03/2021 - 01/2018
2	Ubiquitin-Specific ProteasesIBA 01/2021 - 11/2019
2	LigandsIBA 10/2018 - 10/2004
2	MicroRNAs (MicroRNA)IBA 11/2017 - 04/2013
2	Pharmaceutical PreparationsIBA 01/2013 - 01/2011
1	LipopolysaccharidesIBA 08/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Sincalide FDA Link 12/2021
1	Polysaccharides (Glycans)IBA 11/2021
1	HLX07IBA 11/2021
1	Cetuximab (Erbitux)FDA Link 11/2021
1	VaccinesIBA 10/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	NivolumabIBA 01/2021
1	pembrolizumabIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	CateninsIBA 09/2020
1	polypeptide 1 70kD ribosomal protein S6 kinaseIBA 11/2019
1	Serine (L-Serine)FDA Link 11/2019
1	Threonine (L-Threonine)FDA Link 11/2019
1	CytokinesIBA 12/2018
1	Sitagliptin Phosphate (Januvia)FDA Link 12/2018
1	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2018
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 12/2018
1	acetovanillone (apocynin)IBA 10/2018
1	Sodium Citrate FDA LinkGeneric 10/2018
1	Blood Glucose (Blood Sugar)IBA 10/2018
1	BuffersIBA 10/2018
1	Messenger RNA (mRNA)IBA 10/2018
1	Streptozocin (Streptozotocin)FDA Link 10/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2018
1	X-Linked Inhibitor of Apoptosis ProteinIBA 10/2018
1	graphene oxideIBA 01/2018
1	cadmium sulfideIBA 01/2018
1	Gallic AcidIBA 01/2018
1	Biological ProductsIBA 10/2017
1	Analgesics (Analgesic Drugs)IBA 10/2017
1	AntioxidantsIBA 10/2017
1	Apolipoproteins E (ApoE)IBA 03/2016
1	LipidsIBA 03/2016
1	Angiotensin IIIBA 09/2013
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 09/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2013
1	Blood Proteins (Serum Proteins)IBA 01/2013
1	Platelet-Derived Growth Factor alpha ReceptorIBA 01/2013
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2011
1	C-Reactive ProteinIBA 01/2011
1	Codon (Codons)IBA 09/2010
1	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2010
1	Biotin (Vitamin H)FDA Link 05/2010
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2007
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2004
1	Death Domain ReceptorsIBA 10/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2004
1	Tissue Inhibitor of Metalloproteinase-3IBA 08/2004
1	Indicators and Reagents (Reagents)IBA 08/2004
1	LipofectamineIBA 08/2004
1	Myeloblastin (Proteinase 3)IBA 03/2003
1	Peptides (Polypeptides)IBA 03/2003

Therapy/Procedure

3	Therapeutics 10/2021 - 04/2013
2	Distraction Osteogenesis 05/2022 - 09/2020
1	Immunotherapy 01/2021